Company Filing History:
Years Active: 2019
Title: Cécile Planquette: Innovator in Cancer Treatment
Introduction
Cécile Planquette is a notable inventor based in Palaiseau, France. He has made significant contributions to the field of cancer treatment through his innovative research and patenting efforts. His work focuses on the development of therapeutic combinations that enhance the efficacy of cancer treatments.
Latest Patents
Cécile Planquette holds a patent for "Combinations of inecalcitol with an anti-CD38 agent and their uses for treating cancer." This invention concerns the use of inecalcitol in combination with anti-CD38 agents such as daratumumab, MOR 202, or isatuximab. The patent highlights the potential of these combinations to treat hematological malignancies by increasing or inducing the expression of CD-38 through inecalcitol.
Career Highlights
Cécile Planquette is associated with Hybrigenics S.A., a company known for its focus on innovative biopharmaceutical solutions. His work at Hybrigenics has positioned him as a key player in the development of new cancer therapies.
Collaborations
Cécile collaborates with talented professionals in his field, including Susan Benjamin and Rémi Delansorne. These collaborations enhance the research and development efforts at Hybrigenics, contributing to advancements in cancer treatment.
Conclusion
Cécile Planquette's innovative work in cancer treatment through his patent on inecalcitol combinations demonstrates his commitment to improving therapeutic options for patients. His contributions are vital in the ongoing fight against cancer.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.